Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
63 words
A process for preparing human-specific Type II interferon, comprising: transplanting Type II interferon-producing established human cells into a non-human warm-blooded animal body; multiplying the transplanted cells in a warm-blooded animal body; exposing the multiplied human cells to the action of Type II interferon inducer in vivo or in vitro to induce Type II interferon; and purifying and separating the induced Type II interferon.
Claim 2
Dependent Claim
63 words
A process for preparing human-specific Type II interferon, comprising: transplanting Type II interferon-producing established human cells into a non-human warm-blooded animal body; multiplying the transplanted cells in a warm-blooded animal body; exposing the multiplied human cells to the action of Type II interferon inducer in vivo or in vitro to induce Type II interferon; and purifying and separating the induced Type II interferon.
Claim 3
Dependent Claim
109 words
A process for preparing human-specific Type II interferon, comprising: inoculating Type II interferon-producing established human cells onto a nutrient medium in a diffusion chamber having pores of about 10 -7 to 10 -5 m in diameter; placing the diffusion chamber in or on the body of a non-human warm-blooded animal such that the nutrient body fluids of the animal have access to the chamber; multiplying the inoculated cells while allowing the animal to supply the cells with its nutrient body fluid; exposing the multiplied human cells to the action of a Type II interferon inducer to induce Type II interferon; and purifying and separating the induced Type II interferon.
Claim 4
Dependent Claim
109 words
A process for preparing human-specific Type II interferon, comprising: inoculating Type II interferon-producing established human cells onto a nutrient medium in a diffusion chamber having pores of about 10 -7 to 10 -5 m in diameter; placing the diffusion chamber in or on the body of a non-human warm-blooded animal such that the nutrient body fluids of the animal have access to the chamber; multiplying the inoculated cells while allowing the animal to supply the cells with its nutrient body fluid; exposing the multiplied human cells to the action of a Type II interferon inducer to induce Type II interferon; and purifying and separating the induced Type II interferon.
Claim 5
Dependent Claim
23 words
A process according to claim 1 or claim 2, in which the Type II interferon-producing established human cells are human lymphoblastoid cell lines.
Claim 6
Dependent Claim
47 words
A process according to claim 1 or claim 2, in which the Type II interferon-producing established human cells are HPB-ALL cells, MOLT-3 cells, P 12/Ichikawa cells, HPB-MLT cells, P 8/Seki cells, HCL cells, P 10/Shibata cells, Namalva cells, BALL-1 cells, TALL-1 cells, NALL-1 cells or JBL cells.
Claim 7
Dependent Claim
21 words
A process according to claim 1 or claim 2, in which more than one line of established human cells are used.
Claim 8
Dependent Claim
17 words
A process according to claim 1 or claim 2, in which the non-human warm-blooded animal is mammalian.
Claim 9
Dependent Claim
28 words
A process according to claim 6, in which the mammalian is a dog, cat, monkey, pig, bovine, horse, goat, rabbit, guinea pig, rat, hamster, mouse or nude mouse.
Claim 10
Dependent Claim
31 words
A process according to claim 1 or claim 2, wherein said exposing step comprises exposing the multiplied human cells to both Type I interferon and Type II interferon inducers in combination.
Claim 11
Dependent Claim
39 words
A process according to claim 1 or claim 2, in which the multiplied human cell suspension is exposed to the action of an interferon inducer at an interferon inducer concentration of about 0.001 μg to 10 mg per ml.
Claim 12
Dependent Claim
33 words
A process according to claim 1 or claim 2, in which the multiplied human cells are exposed to the action of an interferon inducer at a temperature of about 20° to 40° C.